Nguyen AnhCo
Nguyen AnhCo, PRES, reported an open-market or private sale at Atara Biotherapeutics, Inc. involving 5062.000000 shares for an estimated $40882.74. Reported holdings after the transaction were 132775.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 17, 2026
- Filing date
- Aug 26, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 137,837 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingATRA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0000905148-26-003960 Common Stock
- Transaction date
- Aug 17, 2026 Filed Aug 26, 2026, 11:45 PM · 9d delay
- Shares
- 5,062 sh $8.08 per share
- Estimated value
- -$40.8k Computed from shares × price
- Holdings after
- 132,775 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - delayed_filing-6 points
reporting_delay_days = 9
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President and CEO
- F1
Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreeme…
- F2
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 17, 2026, on behalf of a group of employees of the Issuer to satisfy the…
0 other transactions
0 recent txs